Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01207271 · ClinicalTrials.gov registry record · NA

A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings

A NA study of Major Depressive Disorder, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
237
Enrollment target
1
Study location

NCT01207271: Completed NA study of Major Depressive Disorder, sponsored by University of Pennsylvania.

NCT01207271 is a NA study of Major Depressive Disorder that has completed, run by University of Pennsylvania. The registered enrollment target is 237 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01207271, a NA study of Major Depressive Disorder, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
237 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to compare supportive-expressive therapy, a type of psychodynamic psychotherapy, with cognitive therapy for the treatment of depression in community mental health consumers. Hypothesized mediators of treatment will also be examined.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Therapy
  • BEHAVIORAL Supportive-Expressive Psychodynamic Therapy

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 237 participants
Start Date 2010-11
Est. Completion 2014-12-09
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT01207271 record still lists

NCT01207271 is an interventional study that assigns participants to a tested intervention. The registered 237 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (37% lower).

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Therapy is the first listed.

NCT01207271 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01207271 about?

NCT01207271 is a clinical study titled "A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings". The goal of this study is to compare supportive-expressive therapy, a type of psychodynamic psychotherapy, with cognitive therapy for the treatment of depression in community mental health consumers. Hypothesized mediators of treatment will also be examined.

What is the current status of trial NCT01207271?

This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2010-11. Estimated completion is 2014-12-09.

What conditions does trial NCT01207271 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT01207271?

The interventions under investigation include: Cognitive Therapy (BEHAVIORAL), Supportive-Expressive Psychodynamic Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01207271?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01207271 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01207271's enrollment target sits among peer trials

237 64th of 282 higher than 219 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05974176 · 237 participants · NA

    Considering Racial and Acculturation Stress in Addressing Trauma

  • NCT05012072 · 238 participants · NA

    Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

  • NCT05400252 · 238 participants · NA

    Whole Health in VA Mental Health: Omnis Salutis

  • NCT06380517 · 238 participants · Phase 3

    Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01207271, the US trial registry maintained by the National Library of Medicine. NCT01207271 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.